<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>1156</ReferenceId>
        <DateLastUpdated>2020-09-30-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15297047</PubmedId>
            <Abstract>A universal influenza virus vaccine that does not require frequent updates and/or annual immunizations will offer significant advantages over current seasonal flu vaccines. The highly conserved influenza virus A M2 membrane protein has been previously suggested as a potential antigen target for such a vaccine. Here, we report systematic evaluation of M2 peptide conjugate vaccines (synthetic peptides of M2 extracellular domain conjugated to keyhole limpet hemocyanin (KLH) or Neisseria meningitidis outer membrane protein complex (OMPC)) in mice, ferrets, and rhesus monkeys. The conjugate vaccines were highly immunogenic in all species tested and were able to confer both protection against lethal challenge of either H1N1 or H3N1 virus in mice and reduce viral shedding in the lower respiratory tracts of mice and ferrets. The protection against lethal challenge in mice could also be achieved by passive transfer of monkey sera containing high M2 antibody titers. In addition, we showed that M2 antisera were cross reactive with M2 peptides derived from a wide range of human influenza A strains, but they failed to react with M2 peptides of the pathogenic H5N1 virus (A/Hong Kong/97). The data presented here will permit better understanding of the potential of an M2-based vaccine approach.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>2993-3003</ArticlePages>
            <ArticleTitle>Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Fan</LastName>
                    <ForeName>Jiang</ForeName>
                </Author>
                <Author>
                    <LastName>Liang</LastName>
                    <ForeName>Xiaoping</ForeName>
                </Author>
                <Author>
                    <LastName>Horton</LastName>
                    <ForeName>Melanie S</ForeName>
                </Author>
                <Author>
                    <LastName>Perry</LastName>
                    <ForeName>Helen C</ForeName>
                </Author>
                <Author>
                    <LastName>Citron</LastName>
                    <ForeName>Michael P</ForeName>
                </Author>
                <Author>
                    <LastName>Heidecker</LastName>
                    <ForeName>Gwen J</ForeName>
                </Author>
                <Author>
                    <LastName>Fu</LastName>
                    <ForeName>Tong-Ming</ForeName>
                </Author>
                <Author>
                    <LastName>Joyce</LastName>
                    <ForeName>Joseph</ForeName>
                </Author>
                <Author>
                    <LastName>Przysiecki</LastName>
                    <ForeName>Craig T</ForeName>
                </Author>
                <Author>
                    <LastName>Keller</LastName>
                    <ForeName>Paul M</ForeName>
                </Author>
                <Author>
                    <LastName>Garsky</LastName>
                    <ForeName>Victor M</ForeName>
                </Author>
                <Author>
                    <LastName>Ionescu</LastName>
                    <ForeName>Roxana</ForeName>
                </Author>
                <Author>
                    <LastName>Rippeon</LastName>
                    <ForeName>Yvette</ForeName>
                </Author>
                <Author>
                    <LastName>Shi</LastName>
                    <ForeName>Li</ForeName>
                </Author>
                <Author>
                    <LastName>Chastain</LastName>
                    <ForeName>Michael A</ForeName>
                </Author>
                <Author>
                    <LastName>Condra</LastName>
                    <ForeName>Jon H</ForeName>
                </Author>
                <Author>
                    <LastName>Davies</LastName>
                    <ForeName>Mary-Ellen</ForeName>
                </Author>
                <Author>
                    <LastName>Liao</LastName>
                    <ForeName>Jason</ForeName>
                </Author>
                <Author>
                    <LastName>Emini</LastName>
                    <ForeName>Emilio A</ForeName>
                </Author>
                <Author>
                    <LastName>Shiver</LastName>
                    <ForeName>John W</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department of Vaccine and Biologics Research, Merck Research Laboratories, 770 Sumneytown Pike, P.O. Box 4, WP16-306, West Point, PA 19486, USA.</Affiliations>
            <ArticleChemicalList>Antibodies, Viral;Bacterial Outer Membrane Proteins;Influenza Vaccines;Vaccines, Conjugate;Vaccines, Subunit;Hemocyanins</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Animals; Antibodies, Viral(analysis; biosynthesis); Bacterial Outer Membrane Proteins(immunology); Enzyme-Linked Immunosorbent Assay; Female; Ferrets; Hemocyanins(immunology); Influenza A virus(immunology); Influenza Vaccines(therapeutic use); Lung(virology); Macaca mulatta; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Nasal Mucosa(virology); Neisseria meningitidis(immunology); Orthomyxoviridae Infections(immunology; prevention &amp; control; virology); Vaccines, Conjugate(immunology); Vaccines, Subunit(immunology); Virus Replication</ArticleMeshHeadingsList>
            <Journal>
                <Volume>22</Volume>
                <Issue>23-24</Issue>
                <Title>Vaccine</Title>
                <Issn>1873-2518</Issn>
                <MedlineTa>Vaccine</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>PR8-M2</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MSLLTEVETPIRNEWGCRCNGSSD</LinearSequence>
                        <StartingPosition>1</StartingPosition>
                        <EndingPosition>24</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P06821.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>211044</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>42597</EpitopeId>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <BCellId>1863368</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 week</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Sibling</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MSLLTEVETPIRNEWGCRCNDSSD</LinearSequence>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>24</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA43276.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>387139</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>A/Aichi/68-M2-KLH</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 doses of 20 µg, administered at intervals of 2 weeks.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A cysteine residue was added to C-terminus of A/Aichi/68-M2 peptide (MSLLTEVETPIRNEWGCRCNDSSD) for conjugation purpose.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Sera from mice immunized with A/Aichi/68-M2 (MSLLTEVETPIRNEWGCRCNDSSD)-KLH cross-reacted to the epitope.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MSLLTEVETPIRNEWGCRCNGSSD</LinearSequence>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>24</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P06821.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>211044</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <BCellId>1857707</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 week</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MSLLTEVETPIRNEWGCRCNGSSD</LinearSequence>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>24</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P06821.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>211044</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>PR8-M2-KLH</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 doses of 20 µg, administered at intervals of 2 weeks.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A cysteine residue was added to C-terminus of the epitope for conjugation purpose.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Sera from the epitope immunized mice cross reacted to Influenza A/Aichi/470/68 M2 protein fragment (1-24).</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Sibling</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MSLLTEVETPIRNEWGCRCNDSSD</LinearSequence>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>24</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA43276.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>387139</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <BCellId>1859803</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 week</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MSLLTEVETPIRNEWGCRCNGSSD</LinearSequence>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>24</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P06821.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>211044</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>PR8-M2-KLH</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 doses of 20 µg, administered at intervals of 2 weeks.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A cysteine residue was added to C-terminus of the epitope for conjugation purpose.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Sera from the epitope immunized mice did not cross react to A/Hong Kong/156/97 (H5N1) Matrix protein 2 peptide (1-24).</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Sibling</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MSLLTEVETLTRNGWGCRCSDSSD</LinearSequence>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>24</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>O70632.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>130763</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <BCellId>1859804</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 week</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MSLLTEVETPIRNEWGCRCNGSSD</LinearSequence>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>24</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P06821.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>211044</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>PR8-M2-KLH</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 doses of 20 µg, administered at intervals of 2 weeks.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A cysteine residue was added to C-terminus of the epitope for conjugation purpose.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Sera from the epitope immunized mice did not cross react to A/Chicken/New York/95 (H7N2) Matrix protein 2 peptide (1-24).</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Sibling</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MSLLTEVETPTRNGWECKCSDSSD</LinearSequence>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>24</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAQ77437.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>236235</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <BCellId>16180</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 week</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MSLLTEVETPIRNEWGCRCNGSSD</LinearSequence>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>24</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P06821.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>211044</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>PR8-M2-KLH</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 doses of 20 µg, administered at intervals of 2 weeks.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A cysteine residue was added to C-terminus of the epitope for conjugation purpose.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MSLLTEVETPIRNEWGCRCNGSSD</LinearSequence>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>24</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P06821.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>211044</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <BCellId>1268160</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 week</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MSLLTEVETPIRNEWGCRCNGSSD</LinearSequence>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>24</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P06821.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>211044</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>PR8-M2-KLH</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 doses of 20 µg, administered at intervals of 2 weeks.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A cysteine residue was added to C-terminus of the epitope for conjugation purpose.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Sera from the epitope immunized mice cross reacted to Influenza A/Hebei/95 M2 protein fragment (1-24).</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Sibling</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MSLLTEVETPIRNEWECRCNGSSD</LinearSequence>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>24</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAD00138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380951</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <BCellId>1857708</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 week</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MSLLTEVETPIRNEWGCRCNGSSD</LinearSequence>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>24</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P06821.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>211044</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>PR8-M2-KLH</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 doses of 20 µg, administered at intervals of 2 weeks.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A cysteine residue was added to C-terminus of the epitope for conjugation purpose.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Sera from the epitope immunized mice cross reacted to Influenza A/A/Wisconsin/3523/88 M2 protein fragment (MSLLTEVETPIRNEWGCKCNDSSD).</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Sibling</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MSLLTEVETPIRNEWGCKCNDSSD</LinearSequence>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>24</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>ABG47908.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380346</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Aichi-M2 1-24</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MSLLTEVETPIRNEWGCRCNDSSD</LinearSequence>
                        <StartingPosition>1</StartingPosition>
                        <EndingPosition>24</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA43276.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>387139</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>42596</EpitopeId>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <BCellId>1863371</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 week</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Sibling</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MSLLTEVETPIRNEWGCRCNGSSD</LinearSequence>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>24</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P06821.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>211044</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 doses of 20 µg, administered at intervals of 2 weeks.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A cysteine residue was added to C-terminus of A/PR/34 peptide (MSLLTEVETPIRNEWGCRCNGSSD) for conjugation purpose.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Sera from mice immunized with A/PR/34 peptide (MSLLTEVETPIRNEWGCRCNGSSD)-KLH cross-reacted to the epitope.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MSLLTEVETPIRNEWGCRCNDSSD</LinearSequence>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>24</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA43276.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>387139</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <BCellId>1857709</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 week</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MSLLTEVETPIRNEWGCRCNDSSD</LinearSequence>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>24</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA43276.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>387139</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 doses of 20 µg, administered at intervals of 2 weeks.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A cysteine residue was added to C-terminus of the epitope for conjugation purpose.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Sera from the epitope immunized mice cross reacted to Influenza A/Hebei/95 M2 protein fragment (1-24).</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Sibling</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MSLLTEVETPIRNEWECRCNGSSD</LinearSequence>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>24</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAD00138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380951</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 4</LocationOfData>
                        <BCellId>1857725</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9544</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MSLLTEVETPIRNEWGCRCNDSSD</LinearSequence>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>24</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA43276.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>387139</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>M2-OMPC</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <GenBankId>AAA25457.1</GenBankId>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>487</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Alum (Aluminum hydroxide gel)</Adjuvant>
                                <Adjuvant>QS21</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 doses of 10, 30, 100, or 300 µg, administered at weeks 0, 8 and 25.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A cysteine residue was added to C- terminus of the epitope for conjugation. Neisseria meningitidis outer membrane protein complex (OMPC) was conjugated to the epitope at C- terminus of the epitope. Half of the groups of monkeys were preimmunized with a commercial vaccine (PedVax) to generated immunity against the carrier for control.</ImmunizationComments>
                        </Immunization>
                        <AdoptiveTransfer>
                            <RecipientOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 weeks</Age>
                            </RecipientOrganism>
                            <TransferredAntibodyMolecule>
                                <TransferredAntibodyMoleculeSourceMaterial>Serum</TransferredAntibodyMoleculeSourceMaterial>
                                <TransferredAntibodyMoleculeImmunoglobulinDomain>Entire Antibody</TransferredAntibodyMoleculeImmunoglobulinDomain>
                                <TransferredAntibodyMoleculePurificationStatus>Polyclonal</TransferredAntibodyMoleculePurificationStatus>
                            </TransferredAntibodyMolecule>
                            <AdoptiveTransferComments>Sera from monkeys immunized with the epitope-OMPC conjugate was adoptively transferred into mice recipients.</AdoptiveTransferComments>
                        </AdoptiveTransfer>
                        <AssayInformation>
                            <AssayTypeId>598</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>10</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>10</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>Adoptive transfer of sera from monkeys immunized with the epitope-OMPC conjugate formulated in Alum plus QS21 protected mice from infection with HKxPR8 (H3N1) virus. But the sera from monkey immunized with the vaccine formulated in Alum lacked the protection, which was reflective of the relatively lower antibody titers in these sera.</AssayComments>
                        </AssayInformation>
                        <Antigen>
                            <AntigenReferenceName>HKxPR8 (H3N1)</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Sibling</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>10000841</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <BCellId>1859805</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 week</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MSLLTEVETPIRNEWGCRCNDSSD</LinearSequence>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>24</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA43276.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>387139</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 doses of 20 µg, administered at intervals of 2 weeks.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A cysteine residue was added to C-terminus of the epitope for conjugation purpose.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Sera from the epitope immunized mice did not cross react to A/Hong Kong/156/97 (H5N1) Matrix protein 2 peptide (1-24).</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Sibling</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MSLLTEVETLTRNGWGCRCSDSSD</LinearSequence>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>24</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>O70632.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>130763</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <BCellId>1859806</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 week</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MSLLTEVETPIRNEWGCRCNDSSD</LinearSequence>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>24</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA43276.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>387139</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 doses of 20 µg, administered at intervals of 2 weeks.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A cysteine residue was added to C-terminus of the epitope for conjugation purpose.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Sera from the epitope immunized mice did not cross react to A/Chicken/New York/95 (H7N2) Matrix protein 2 peptide (1-24).</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Sibling</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MSLLTEVETPTRNGWECKCSDSSD</LinearSequence>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>24</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAQ77437.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>236235</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 3</LocationOfData>
                        <BCellId>1857719</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9669</OrganismId>
                                <Age>4-6 months</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo to prevent or reduce disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MSLLTEVETPIRNEWGCRCNDSSD</LinearSequence>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>24</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA43276.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>387139</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Aichi-M2 conjugate vaccine</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <GenBankId>AAA25457.1</GenBankId>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>487</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>QS21</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 doses of 100 µg, administered at intervals of 4 weeks.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A cysteine residue was added to either N- or C- terminus of the epitope for conjugation. Keyhole limpet hemocyanin (KLH) or Neisseria meningitidis outer membrane protein complex (OMPC) was conjugated to the epitope at either N- or C- terminus of the epitope.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>125</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope conjugated vaccines protected ferrets from infection with H1N1 virus as measured by reducing viral shedding in the lower respiratory tracts (lung), but there was no apparent difference in terms of rate of nasal shedding and viral titers between the epitope conjugate vaccinated and control groups.</AssayComments>
                        </AssayInformation>
                        <Antigen>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Sibling</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>211044</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <BCellId>16220</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 week</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo to prevent or reduce disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MSLLTEVETPIRNEWGCRCNDSSD</LinearSequence>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>24</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA43276.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>387139</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Aichi-M2-KLH</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 doses of 20 µg, administered at intervals of 2 weeks.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>125</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope conjugated to KLH protected mice from infection with PR8 virus as measured by weight change and mortality.</AssayComments>
                        </AssayInformation>
                        <Antigen>
                            <AntigenReferenceName>PR8 (H1N1)</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Sibling</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>211044</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figures 2 and 3</LocationOfData>
                        <BCellId>1857717</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 week</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo to prevent or reduce disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MSLLTEVETPIRNEWGCRCNDSSD</LinearSequence>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>24</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA43276.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>387139</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Aichi-M2-KLH</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Adjuvant>QS21</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 doses of 20 µg, administered at intervals of 2 weeks.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were immunized with either Aichi-M2-KLH vaccine plus complete Freund’s and incomplete Freund’s adjuvant or Aichi-M2-KLH vaccine plus QS21 adjuvant.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>125</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope conjugated to KLH protected mice from infection with HKxPR8(H3N1) as measured by weight change, mortality, nasal and lung wash viral titers at the respective time points (at day 1, 3, 5, 7 and 9 after HKxPR8 virus challenge).</AssayComments>
                        </AssayInformation>
                        <Antigen>
                            <AntigenReferenceName>HKxPR8(H3N1)</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Sibling</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>10000841</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <BCellId>1857710</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 week</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MSLLTEVETPIRNEWGCRCNDSSD</LinearSequence>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>24</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA43276.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>387139</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 doses of 20 µg, administered at intervals of 2 weeks.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A cysteine residue was added to C-terminus of the epitope for conjugation purpose.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Sera from the epitope immunized mice cross reacted to Influenza A/A/Wisconsin/3523/88 M2 protein fragment (MSLLTEVETPIRNEWGCKCNDSSD).</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Sibling</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MSLLTEVETPIRNEWGCKCNDSSD</LinearSequence>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>24</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>ABG47908.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380346</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <BCellId>1268187</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9669</OrganismId>
                                <Age>4-6 months</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MSLLTEVETPIRNEWGCRCNDSSD</LinearSequence>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>24</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA43276.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>387139</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Aichi-M2 conjugate vaccine</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <GenBankId>AAA25457.1</GenBankId>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>487</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>QS21</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 doses of 100 µg, administered at intervals of 4 weeks.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A cysteine residue was added to either N- or C- terminus of the epitope for conjugation. Keyhole limpet hemocyanin (KLH) or Neisseria meningitidis outer membrane protein complex (OMPC) was conjugated to the epitope at either N- or C- terminus of the epitope.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Among the four different vaccines, C-terminal conjugates with either KLH or OMPC carrier elicited higher titers than their N-terminal counterparts, and conjugates prepared with OMPC carrier elicited higher titers than those with KLH carrier. The epitope covalently coupled through the C-terminus to OMPC (M2-OMPC) represented the most immunogenic form among the four conjugates tested.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MSLLTEVETPIRNEWGCRCNDSSD</LinearSequence>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>24</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA43276.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>387139</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <BCellId>1268162</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 week</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MSLLTEVETPIRNEWGCRCNDSSD</LinearSequence>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>24</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA43276.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>387139</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 doses of 20 µg, administered at intervals of 2 weeks.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A cysteine residue was added to C-terminus of the epitope for conjugation purpose.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Sera from the epitope immunized mice cross reacted to Influenza A/Puerto Rico/8/34 M2 protein fragment (1-24).</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Sibling</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MSLLTEVETPIRNEWGCRCNGSSD</LinearSequence>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>24</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P06821.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>211044</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <BCellId>1268186</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9544</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MSLLTEVETPIRNEWGCRCNDSSD</LinearSequence>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>24</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA43276.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>387139</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>M2-OMPC</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <GenBankId>AAA25457.1</GenBankId>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>487</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Alum (Aluminum hydroxide gel)</Adjuvant>
                                <Adjuvant>QS21</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 doses of 10, 30, 100, or 300 µg, administered at weeks 0, 8 and 25.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A cysteine residue was added to C- terminus of the epitope for conjugation. Neisseria meningitidis outer membrane protein complex (OMPC) was conjugated to the epitope at C- terminus of the epitope. Half of the groups of monkeys were preimmunized with a commercial vaccine (PedVax) to generated immunity against the carrier for control.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope-OMPC conjugate vaccine elicited significant epitope-specific titers after a single immunization. These responses were further boosted after second and third immunizations. There was no apparent dose effect on both OMPC-immunized and OMPC-naive monkeys. The conjugates formulated in Alum plus QS21 showed 5- to 10-fold higher antibody titers than the average titers elicited by the same dose of the conjugate formulated in Alum alone.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MSLLTEVETPIRNEWGCRCNDSSD</LinearSequence>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>24</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA43276.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>387139</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <BCellId>1268161</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 week</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MSLLTEVETPIRNEWGCRCNDSSD</LinearSequence>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>24</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA43276.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>387139</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 doses of 20 µg, administered at intervals of 2 weeks.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A cysteine residue was added to C-terminus of the epitope for conjugation purpose.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MSLLTEVETPIRNEWGCRCNDSSD</LinearSequence>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>24</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA43276.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>387139</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A/Hebei/19/95 M2 protein peptide</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MSLLTEVETPIRNEWECRCNGSSD</LinearSequence>
                        <StartingPosition>1</StartingPosition>
                        <EndingPosition>24</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAD00138.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>380951</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>153427</EpitopeId>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <BCellId>1857712</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 week</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Sibling</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MSLLTEVETPIRNEWGCRCNGSSD</LinearSequence>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>24</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P06821.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>211044</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>PR8-M2-KLH</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 doses of 20 µg, administered at intervals of 2 weeks.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A cysteine residue was added to C-terminus of the epitope for conjugation purpose.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Sera from mice immunized with PR8-M2 peptide (fragment 1-24) cross reacted to the epitope by ELISA.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MSLLTEVETPIRNEWECRCNGSSD</LinearSequence>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>24</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAD00138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380951</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <BCellId>1857713</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 week</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Sibling</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MSLLTEVETPIRNEWGCRCNDSSD</LinearSequence>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>24</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA43276.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>387139</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Aichi-M2-KLH</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 doses of 20 µg, administered at intervals of 2 weeks.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A cysteine residue was added to C-terminus of the epitope for conjugation purpose.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Sera from mice immunized with Aichi influenza virus M2 peptide (fragment 1-24) cross reacted to the epitope by ELISA.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MSLLTEVETPIRNEWECRCNGSSD</LinearSequence>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>24</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAD00138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>380951</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A/Wisconsin/3523/88 M2 peptide</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MSLLTEVETPIRNEWGCKCNDSSD</LinearSequence>
                        <SourceMolecule>
                            <IedbAccession>SRC279996</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>380346</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>153428</EpitopeId>
                <EpitopeEvidenceCode>Internal Identifier-no external match available</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <BCellId>1857715</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 week</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Sibling</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MSLLTEVETPIRNEWGCRCNDSSD</LinearSequence>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>24</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA43276.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>387139</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Aichi-M2-KLH</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 doses of 20 µg, administered at intervals of 2 weeks.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A cysteine residue was added to C-terminus of the epitope for conjugation purpose.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Sera from mice immunized with Aichi influenza virus M2 peptide (fragment 1-24) cross reacted to the epitope by ELISA.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MSLLTEVETPIRNEWGCKCNDSSD</LinearSequence>
                                        <SourceMolecule>
                                            <IedbAccession>SRC279996</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>380346</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <BCellId>1857714</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 week</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Sibling</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MSLLTEVETPIRNEWGCRCNGSSD</LinearSequence>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>24</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P06821.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>211044</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>PR8-M2-KLH</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 doses of 20 µg, administered at intervals of 2 weeks.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A cysteine residue was added to C-terminus of the epitope for conjugation purpose.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Sera from mice immunized with PR8-M2 peptide (fragment 1-24) cross reacted to the epitope by ELISA.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MSLLTEVETPIRNEWGCKCNDSSD</LinearSequence>
                                        <SourceMolecule>
                                            <IedbAccession>SRC279996</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>380346</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A/Hong Kong/156/97 (H5N1) peptide</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MSLLTEVETLTRNGWGCRCSDSSD</LinearSequence>
                        <StartingPosition>1</StartingPosition>
                        <EndingPosition>24</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>O70632.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>130763</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>42595</EpitopeId>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <BCellId>1859807</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 week</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Sibling</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MSLLTEVETPIRNEWGCRCNGSSD</LinearSequence>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>24</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P06821.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>211044</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>PR8-M2-KLH</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 doses of 20 µg, administered at intervals of 2 weeks.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A cysteine residue was added to C-terminus of the epitope for conjugation purpose.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Sera from mice immunized with PR8-M2 peptide (fragment 1-24) did not cross react to the epitope by ELISA.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MSLLTEVETLTRNGWGCRCSDSSD</LinearSequence>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>24</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>O70632.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>130763</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <BCellId>1859808</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 week</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Sibling</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MSLLTEVETPIRNEWGCRCNDSSD</LinearSequence>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>24</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA43276.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>387139</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Aichi-M2-KLH</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 doses of 20 µg, administered at intervals of 2 weeks.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A cysteine residue was added to C-terminus of the epitope for conjugation purpose.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Sera from mice immunized with Aichi influenza virus M2 peptide (fragment 1-24) did not cross react to the epitope by ELISA.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MSLLTEVETLTRNGWGCRCSDSSD</LinearSequence>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>24</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>O70632.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>130763</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>A/Chicken/New York/95 (H7N2) peptide</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MSLLTEVETPTRNGWECKCSDSSD</LinearSequence>
                        <StartingPosition>1</StartingPosition>
                        <EndingPosition>24</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAQ77437.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>236235</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>153429</EpitopeId>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <BCellId>1859809</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 week</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Sibling</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MSLLTEVETPIRNEWGCRCNGSSD</LinearSequence>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>24</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P06821.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>211044</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>PR8-M2-KLH</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 doses of 20 µg, administered at intervals of 2 weeks.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A cysteine residue was added to C-terminus of the epitope for conjugation purpose.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Sera from mice immunized with PR8-M2 peptide (fragment 1-24) did not cross react to the epitope by ELISA.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MSLLTEVETPTRNGWECKCSDSSD</LinearSequence>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>24</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAQ77437.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>236235</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <BCellId>1859810</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 week</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Sibling</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MSLLTEVETPIRNEWGCRCNDSSD</LinearSequence>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>24</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA43276.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>387139</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Aichi-M2-KLH</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 doses of 20 µg, administered at intervals of 2 weeks.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A cysteine residue was added to C-terminus of the epitope for conjugation purpose.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Sera from mice immunized with Aichi influenza virus M2 peptide (fragment 1-24) did not cross react to the epitope by ELISA.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MSLLTEVETPTRNGWECKCSDSSD</LinearSequence>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>24</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAQ77437.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>236235</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

